NCT00202189View on ClinicalTrials.gov

Effects of Inhaled Corticosteroids in Chronic Obstructive Pulmonary Disease (COPD)

PHASE4CompletedINTERVENTIONAL
Enrollment

4

Participants

Timeline

Start Date

September 30, 2005

Primary Completion Date

November 30, 2005

Study Completion Date

November 30, 2005

Conditions
Chronic Obstructive Pulmonary Disease
Interventions
DRUG

Budesonide

Nebulized Budesonide (4 mL) or saline solution (0.9% NaCl) (4 mL) will be administered to subjects once only.

Trial Locations (1)

K7L 2V7

Respiratory Investigation Unit, Kingston

All Listed Sponsors
lead

Queen's University

OTHER

NCT00202189 - Effects of Inhaled Corticosteroids in Chronic Obstructive Pulmonary Disease (COPD) | Biotech Hunter | Biotech Hunter